Trending News Today: Experimental Endometrial Cancer Drug Shows Promise

On Tuesday, GlaxoSmithKline (GSK) announced positive results from its clinical trial testing the experimental drug dostarlimab in women with recurrent or advanced endometrial cancer, Reuters reported. According to the article, data from the GARNET study showed that dostarlimab demonstrated clinically meaningful and durable response rates when used to treat certain types of tumors. GSK said it would apply for marketing approval for dostarlimab by the end of 2019, the article reported.
 
A new study published in The Lancet Psychiatry indicates that consuming high-potency cannabis on a daily basis may increase the risk of psychosis later on, NPR reported. According to the article, the study identified 901 individuals who were diagnosed with their first episode of psychosis between May 2010 and April 2015 at a mental health facility and compared these individuals’ habits, such as use of marijuana, with a control group. The findings showed that

... read more at: https://www.specialtypharmacytimes.com/news/trending-news-today-experimental-endometrial-cancer-drug-shows-promise

by